570 related articles for article (PubMed ID: 36304935)
1. Clinical carbapenem-resistant
Shahid M; Ahmad N; Saeed NK; Shadab M; Joji RM; Al-Mahmeed A; Bindayna KM; Tabbara KS; Dar FK
Front Cell Infect Microbiol; 2022; 12():1033305. PubMed ID: 36304935
[TBL] [Abstract][Full Text] [Related]
2. High frequency of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae isolates in central Iran.
Abbasi E; Ghaznavi-Rad E
BMC Microbiol; 2023 Apr; 23(1):98. PubMed ID: 37038144
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant hypermucoviscous
Wang Q; Chen M; Ou Q; Zheng L; Chen X; Mao G; Fang J; Jin D; Tang X
Front Cell Infect Microbiol; 2022; 12():1083009. PubMed ID: 36619764
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility profile of
Sharma S; Banerjee T; Yadav G; Kumar A
Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
[TBL] [Abstract][Full Text] [Related]
5. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
Zornic S; Petrovic I; Lukovic B
Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
[TBL] [Abstract][Full Text] [Related]
7. Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from
Pragasam AK; Veeraraghavan B; Shankar BA; Bakthavatchalam YD; Mathuram A; George B; Chacko B; Korula P; Anandan S
Indian J Med Microbiol; 2019; 37(1):34-41. PubMed ID: 31424008
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
[TBL] [Abstract][Full Text] [Related]
9. Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.
Iraz M; Özad Düzgün A; Sandallı C; Doymaz MZ; Akkoyunlu Y; Saral A; Peleg AY; Özgümüş OB; Beriş FŞ; Karaoğlu H; Çopur Çiçek A
Ann Lab Med; 2015 Nov; 35(6):595-601. PubMed ID: 26354347
[TBL] [Abstract][Full Text] [Related]
10. Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia.
Uz Zaman T; Aldrees M; Al Johani SM; Alrodayyan M; Aldughashem FA; Balkhy HH
Int J Infect Dis; 2014 Nov; 28():186-92. PubMed ID: 25245001
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of a Stable and Transferable
Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B
Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies for OXA-48-like and NDM producing
Isler B; Aslan AT; Akova M; Harris P; Paterson DL
Expert Rev Anti Infect Ther; 2022 Nov; 20(11):1389-1400. PubMed ID: 36150216
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
14. [Colistin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a pediatric hospital from Corrientes, Argentina].
Pellegrini JL; Aguirre C; Soto SM; Lovera LMR; Lösch LS; Conza JAD; Merino LA
Rev Chilena Infectol; 2022 Apr; 39(2):109-116. PubMed ID: 35856982
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
Ahmed MAEE; Yang Y; Yang Y; Yan B; Chen G; Hassan RM; Zhong LL; Chen Y; Roberts AP; Wu Y; He R; Liang X; Qin M; Dai M; Zhang L; Li H; Yang F; Xu L; Tian GB
mSphere; 2021 May; 6(3):. PubMed ID: 34011682
[TBL] [Abstract][Full Text] [Related]
16. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
Maraki S; Mavromanolaki VE; Magkafouraki E; Moraitis P; Stafylaki D; Kasimati A; Scoulica E
Infection; 2022 Apr; 50(2):467-474. PubMed ID: 34854060
[TBL] [Abstract][Full Text] [Related]
18. Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates.
Arabacı Ç; Dal T; Başyiğit T; Genişel N; Durmaz R
J Infect Dev Ctries; 2019 Jun; 13(6):504-509. PubMed ID: 32058985
[TBL] [Abstract][Full Text] [Related]
19.
Goel A; Gupta V; Singhal L; Palta S; Chander J
Indian J Med Res; 2021 Mar; 154(3):520-526. PubMed ID: 35345078
[TBL] [Abstract][Full Text] [Related]
20. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
